PEPTIDES AS NEUROTRANSMITTERS IN VASCULAR AUTONOMIC NEURONS

Clinical and Experimental Pharmacology and Physiology

Volumn 22, Issue 11, 1995, Pages 792-802

  Morris, J L ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

autonomic neurons; co transmission; neuropeptide; neurotransmitter; vasoconstriction; vasodilation.

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALINAMIDE[2 DEXTRO ALANINE]; GUANETHIDINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NALOXONE; NEUROPEPTIDE Y; NORADRENALIN; PRAZOSIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; AUTONOMIC NERVOUS SYSTEM; GUINEA PIG; NONHUMAN; REVIEW; VASOCONSTRICTION; VASODILATATION;

ANIMAL; AUTONOMIC NERVOUS SYSTEM; BLOOD VESSELS; GUINEA PIGS; NEUROPEPTIDE Y; NEUROPEPTIDES; VASOCONSTRICTION;

EID: 0028880363     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1995.tb01938.x     Document Type: Article

References (119)

1. Effects of neuropeptide Y on contraction, relaxation, and membrane potential of rabbit cerebral arteries
2. Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf
3. Identification of benzomorphan‐kappa opiate receptors in cerebral arteries which subserve relaxation
4. Vasoactive intestinal polypeptide in relation to penile erection in the cat evoked by pelvic and by hypogastric nerve stimulation
5. The peptidergic motoneurone
6. Dual vasoconstrictor and vasodilator innervation of the uterine arterial supply in the guinea‐pig
7. Active polypeptides of nonmammalian origin
8. Evidence that vasoactive intestinal polypeptide is a dilator transmitter to some cerebral and extracerebral cranial arteries
9. Evidence that vasoactive intestinal polypeptide (VIP) mediates neurogenic vasodilation of feline cerebral arteries
10. Localization of nitric oxide synthase indicating a neural role for nitric oxide
11. Influence of stimulation train length on the opioid‐induced inhibition of norepinephrine release in the rabbit ear artery
12. Purinergic nerves
13. Enkephalin lowers vascular resistance in dog hindlimb via a peripheral nonlimb site
14. Calcitonin gene‐related peptide in rat spinal cord motorneurons: Subcellular distribution and changes induced by axotomy
15. Non‐adrenergic, non‐cholinergic transmission in the autonomic nervous system
16. Pituitary adenylate cyclase activating peptide (PACAP) in guinea‐pig lung: Distribution and dilatory effects
17. Type I receptors for PACAP (a neuropeptide even more potent than VIP)
18. Effects of neuropeptide Y and galanin on autonomic control of heart rate in the toad, Bufo marinus
19. Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brushtailed possum
20. Neuropeptide Y (NPY) reduces field stimulation‐evoked release of noradrenaline and enhances force of contraction in the rat portal vein
21. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats
22. 8–37, a calcitonin gene‐related peptide antagonist revealing calcitonin gene‐related peptide receptor heterogeneity in brain and periphery
23. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels
24. Neuropeptide Y co‐exists and co‐operates with noradrenaline in perivascular nerve fibres
25. Galanin: Neuromodulatory and direct contractile effects on smooth muscle preparations
26. 1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y‐evoked vasoconstriction
27. Tissue differences in the effects of neuropeptide Y, adenosine and noradrenaline at the second messenger level
28. Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Biochemical and immunohistochemical evidence
29. 34]‐Neuropeptide Y: A specific YI receptor agonist
30. Co‐existence and co‐function
31. Vasoconstrictor, vasodilator and pilomotor pathways in sympathetic ganglia of guinea‐pigs
32. Sympathetic noradrenergic neurons containing dynorphin but not neuropeptide Y innervate small cutaneous blood vessels of guinea‐pigs
33. Pathway‐specific patterns of co‐existence of substance P, calcitonin gene‐related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea‐pig
34. Two immuno‐histochemically‐identified populations of calcitonin gene‐related peptide (CGRP)‐immunoreactive axons in human skin
35. Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non‐vascular smooth muscle
36. Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system
37. High frequency stimulation of the facial nerve results in local release of vasoactive intestinal polypeptide in the anaesthetised cat
38. Unmasking the vasoconstrictor response to neuropeptide Y and its interaction wth vasodiiating agents in vitro
39. Peptide‐containing nerve fibres in guinea‐pig coronary arteries: Immunohistochemistry, ultrastructure and vasomotility
40. Peptidergic innervation of human epicardial coronary arteries
41. Enkephalin‐induced dilatation of piaf arteries in vitro probably mediated by opiate receptors
42. Cloned human neuropeptide Y receptor couples to two different second messenger systems
43. Peptide neurones in the peripheral tissues including the urinary tract: lmmunohistochemical studies
44. Co‐existence and interaction of neuropeptides and substance P in primary sensory neurons, with special reference to galanin
45. Cardiovascular effects of endogenous opiate systems
46. Peptidergic sensory neurons in the control of vascular functions: Mechanisms and significance in the cutaneous and splanchnic beds
47. Cerebral vascular adenylate cyclase: Evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone
48. Evidence that vascular actions of PHI are mediated by a VIP‐preferring receptor
49. Presynaptic opioid delta‐receptors in the rabbit mesenteric artery
50. β‐endorphin‐sensitive opioid receptors in the rat tail artery
51. Cardiovascular and respiratory actions of pituitary adenulate cyclase‐activating polypeptides
52. The role of vasoactive intestinal poly‐peptide as a neurotransmitter in canine penile erection: A combined in vivo and immunohistochemical study
53. Neurogenic dilatation and constriction of rat superior mesenteric artery in vitro: Mechanisms and mediators
54. A possible neural source of nitric oxide in the rat penis
55. Transient cerebral vasodilatory effect of neuropeptide Y mediated by nitric oxide
56. Galanin‐ and neuropeptide Y‐like immunoreactivities coexist in paravertebral sympathetic neurons of the cat
57. Adrenergic and non‐adrenergic mechanisms in sympathetic vascular control of the nasal mucosa
58. Proportions of renal and splenic postganglionic sympathetic populations containing galanin and dopamine beta hydroxylase
59. Evidence of the co‐existence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies
60. Multiple co‐existence of peptides and classical transmitters in peripheral autonomic and sensory neurons: Functional and pharmacological implications
61. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to a‐adrenoceptor blockade
62. Vascular effects of the peptides PYY and PHI: Comparison with APP and VIP
63. Coexistence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man
64. Co‐release of vasoactive intestinal polypeptide and peptide histidine isoleucine in relation to atropine‐resistant vasodilation in cat sub‐mandibular salivary gland
65. Co‐release of neuropeptide Y and catecholamines during physical exercise in man
66. Frequency‐ and reserpine‐dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen
67. Neuropeptide Y receptor in pig spleen: Binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction
68. Evidence for co‐transmitter role of neuropeptide Y in the pig spleen
69. 2+ increases in vascular smooth muscle cells
70. Projections of nitric oxide synthase containing fibres from the sphenopalatine ganglion to cerebral arteries in the rat
71. Analysis of systemic and pulmonary vascular responses to PACAP and VIP: Role of adrenal catecholamines
72. Isolation of a neuropeptide corresponding to the N‐terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues
73. Neuropeptide Y inhibits relaxations of the guinea‐pig uterine artery produced by vasoactive intestinal peptide
74. Roles of neuropeptide Y and noradrenaline in sympathetic neurotransmission to the thoracic vena cava and aorta of guinea‐pigs
75. Pertussis toxin attenuates post‐synaptic actions of neuropeptide Y on the guinea‐pig uterine artery
76. Co‐transmission from autonomic vasodilator neurons supplying the uterine artery
77. Selective constriction of small cutaneous arteries by NPY matches distribution of NPY in sympathetic axons
78. Plasma neuropeptide Y levels rise in patients undergoing exercise for investigation of chest pain
79. Co‐transmission and neuromodulation
80. Increased levels of dopamine‐P‐hydroxylase‐like immunoreactivity in non‐noradrenergic axons supplying the guinea‐pig uterine artery after 6‐hydroxydo‐pamine treatment
81. Colocalization of neuropeptide Y, vasoactive intestinal polypeptide and dynorphin in non‐noradrenergic axons of the guinea‐pig uterine artery
82. Galanin is more common than NPY in vascular sympathetic neurons of the brush‐tailed possum
83. Plasma neuropeptide Y concentration is increased after haemorrhage in conscious rats: Relative contributions of sympathetic nerves and the adrenal medulla
84. Evidence that neuropeptide Y released from noradrenergic axons causes prolonged contraction of the guinea‐pig uterine artery
85. Analogues of vasoactive intestinal peptide (VIP) contract the guinea‐pig uterine artery but do not antagonise VIP‐induced relaxations
86. Comparison of the NPY receptors mediating vasoconstriction of the guinea‐pig uterine artery and thoracic vena cava using a range of NPY analogues
87. Effects of porcine galanin on the mesenteric microcirculation and arteriolar smooth muscle in the rat
88. Vasodilator effect of pituitary adenylate cyclase activating peptide (PACAP) on femoral blood flow in dogs
89. Actions of neuropeptide Y on innervated and denervated rat tail arteries
90. Nerve‐induced nonadrenergic vasoconstriction and vasodilation in skeletal muscle
91. Renin angiotensin system, biochemistry and mechanism of action
92. Actions of calcium antagonists on pre‐ and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro
93. Influence of sympathetic discharge pattern on noradrenaline and neuropeptide Y release
94. No effect of D‐myo‐inositol‐l,2,6–triphosphate on vasoconstriction evoked by neuropeptide Y and non‐adrenergic sympathetic nerve stimulation
95. Calcitonin gene‐related peptide‐like immunoreactivity in motor neuron pools innervating different hindlimb muscles in the rat
96. 34]NPY, a selective functional postjunctional agonist at neuropeptide Y receptors in anaesthetised rats
97. Pre‐and postjunctional actions of neuropeptide Y and related peptides
98. 34]Neuropeptide Y selectively identifies postjunctionally‐mediated actions of neuropeptide Y in vivo in rat and dogs
99. Antagonism of pre‐ and postjunctional responses to neuropeptide Y and sympathetic stimulation by D‐myo‐inositol‐1,2,6–triphosphate in the anaesthetised dog
100. Evolution of neurohypophysial hormones and their receptors
101. A potent non‐peptide antagonist of the substance P (NKI) receptor
102. D‐myoinositol‐l,2,6–triphosphate is a selective antagonist of neuropeptide Y‐induced pressor responses in the pithed rat
103. Neuropeptide Y co‐exists with vasoactive intestinal polypeptide and acetylcholine in parasympathetic cerebrovascular nerves originating in the sphenopalatine, otic and internal carotid ganglia of the rat
104. Isolation and characterisation of the intestinal peptide porcine PHI (PHI‐27), a new member of the glucagonsecretin family
105. G‐monomethyl arginine (L‐NMM A) of the response to nerve stimulation in isolated dog mesenteric and cerebral arteries
106. Impairment by damage of the pterygopalatine ganglion of nitroxergic vasodilator nerve function in canine cerebral and retinal arteries
107. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine
108. PACAP, a VIP‐like peptide: Immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow
109. The effects of galanin and galanin fragments on cardiac vagal action and blood pressure in the anaesthetised cat
110. Galanin antagonist effects on cardiac vagal inhibitory actions of sympathetic stimulation in anaesthetised cats and dogs
111. Effects of enkephalins, morphine, and naloxone on pial arteries during perivascular microapplication
112. 2
113. A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co‐transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP)
114. Pituitary adenylate cyclase‐activating polypeptide: A novel, long‐lasting, endothelium‐independent vasorelaxant
115. Beta‐endorphin. Vasodilating effect on the microcirculatory system of hamster cheek pouch
116. Pre‐ and postjunctional effects of neuropeptide Y on the rabbit isolated ear artery
117. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub‐types on arterioles of the guinea‐pig small intestine and the rat brain